Jobbörse
Finde Jobs in deiner Nähe – ob vor Ort, hybrid oder remote.- Ähnliche Jobs zu: Principal Formulation Development Scientist I - Oxford
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreHighclere
Senior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Scientist - Infectious Diseases - Oxford
ImmunocoreHighclereScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreNorth HinkseySenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreSutton WickSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreMoreton in MarshSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreMapledurhamSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreWaltham Saint LawrenceSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreStow on the WoldSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreMortimer CommonSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreUnited KingdomSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Senior Scientist I - Characterisation | CMC - Oxford
ImmunocoreChalfont Saint GilesSenior Scientist I - Characterisation | CMC - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a n
Scientist - Infectious Diseases - Oxford
ImmunocoreMapledurhamScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
Scientist - Infectious Diseases - Oxford
ImmunocoreMoreton in MarshScientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generatio
